NCT01362075

Brief Summary

The purpose of this study is to determine the efficacy of local infiltration analgesia as compared to 48-hour interscalene block in treating pain after shoulder arthroplasty. The investigators hypothesize a reduced pain score and use of supplemental analgesic medication during the first three postoperative days using local infiltration analgesia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 27, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

August 8, 2014

Status Verified

August 1, 2014

Enrollment Period

3 years

First QC Date

May 26, 2011

Last Update Submit

August 7, 2014

Conditions

Keywords

Shoulder ArthroplastyLocal infiltration analgesia

Outcome Measures

Primary Outcomes (1)

  • Supplemental analgesics ingested

    First 24 hours postoperatively

Secondary Outcomes (2)

  • Pain score

    First 72 hours postoperatively

  • Supplemental analgesics ingested

    First 72 hours postoperatively

Study Arms (2)

Local infiltration analgesia

EXPERIMENTAL
Procedure: Local infiltration analgesia

Interscalene catheter

ACTIVE COMPARATOR
Procedure: Interscalene catheter

Interventions

150 ml ropivacaine, of which 100 ml is with adrenalin

Also known as: LIA
Local infiltration analgesia

7 ml ropivacaine interscalene block via catheter, subsequently given 5 ml/h and possibility of 5 ml bolus for the first 48 hours.

Also known as: interscalene block
Interscalene catheter

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective primary shoulder arthroplasty

You may not qualify if:

  • reverse or delta prosthesis
  • recent fracture near the shoulder
  • allergic to amid-type local analgesics
  • operation not under general anaesthesia
  • incompetent, pregnant, below 18 or above 90 years old
  • severe chronic neurogenic pain or sensory disturbances in the shoulder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Aarhus University Hospital, Aarhus Hospital

Aarhus, Denmark, DK-8000, Denmark

Location

Horsens Hospital

Horsens, Denmark, DK-8700, Denmark

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Karen T Bjørnholdt, MD

    Horsens Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 26, 2011

First Posted

May 27, 2011

Study Start

July 1, 2011

Primary Completion

July 1, 2014

Study Completion

October 1, 2014

Last Updated

August 8, 2014

Record last verified: 2014-08

Locations